26 related articles for article (PubMed ID: 8225505)
1. Detection of DNA adducts in human oral tissue: correlation of adduct levels with tobacco smoking and differential enhancement of adducts using the butanol extraction and nuclease P1 versions of 32P postlabeling.
Jones NJ; McGregor AD; Waters R
Cancer Res; 1993 Apr; 53(7):1522-8. PubMed ID: 8453617
[TBL] [Abstract][Full Text] [Related]
2. Development of a human biomonitoring assay using buccal mucosa: comparison of smoking-related DNA adducts in mucosa versus biopsies.
Stone JG; Jones NJ; McGregor AD; Waters R
Cancer Res; 1995 Mar; 55(6):1267-70. PubMed ID: 7882320
[TBL] [Abstract][Full Text] [Related]
3. Smoking-related DNA adducts in human cervical biopsies.
Phillips DH; Ni Shé M
IARC Sci Publ; 1993; (124):327-30. PubMed ID: 8225502
[TBL] [Abstract][Full Text] [Related]
4. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
5. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
[TBL] [Abstract][Full Text] [Related]
6. 32P-postlabelling analysis of human tissues and its potential use for biomonitoring.
Jones NJ; McGregor AD; Hoskins PL; Waters R
IARC Sci Publ; 1993; (124):349-55. PubMed ID: 8225505
[TBL] [Abstract][Full Text] [Related]
7. Monitoring tobacco smoke-induced DNA damage by 32P-postlabelling.
Randerath E; Randerath K
IARC Sci Publ; 1993; (124):305-14. PubMed ID: 8225499
[TBL] [Abstract][Full Text] [Related]
8. Monitoring occupational exposure to carcinogens.
Schoket B
IARC Sci Publ; 1993; (124):341-7. PubMed ID: 8225504
[TBL] [Abstract][Full Text] [Related]
9. Human biomonitoring: state of the art.
Angerer J; Ewers U; Wilhelm M
Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
[TBL] [Abstract][Full Text] [Related]
10. I-compounds--endogenous DNA markers of nutritional status, ageing, tumour promotion and carcinogenesis.
Randerath K; Li D; Moorthy B; Randerath E
IARC Sci Publ; 1993; (124):157-65. PubMed ID: 8225479
[TBL] [Abstract][Full Text] [Related]
11. 32P-postlabelling in studies of hormonal carcinogenesis.
Liehr JG; Han X; Bhat HK
IARC Sci Publ; 1993; (124):149-55. PubMed ID: 8225478
[TBL] [Abstract][Full Text] [Related]
12. Human biomonitoring and the 32P-postlabeling assay.
Beach AC; Gupta RC
Carcinogenesis; 1992 Jul; 13(7):1053-74. PubMed ID: 1638670
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
